Matt’s Take
Insights and opinions from senior medicine writer Matthew Herper
Most Read
The fall of Eric Lander and the end of science’s ‘big ego’ era
Why Biogen’s Medicare mess is bad for the pharmaceutical industry
Robert Califf is a fervent believer in data. At the FDA, will that be enough?
The tragedy of Johnson & Johnson’s Covid vaccine
By approving Biogen’s Alzheimer’s drug, the FDA is shifting its rules. That is a giant risk
Having pandemic panic attacks about virus variants? National preparation is the cure
Antibody drugs seem to work. But the virus is moving faster than we can make them
All Coverage
advertisement
